- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
PET/MRI Combo Wins FDA Approval
The U.S. Food and Drug Administration on Friday approved the Siemens Biograph mMR system for use in the United States. It’s the first device approved to simultaneously perform a positron emission tomography (PET) and magnetic resonance imaging (MRI) scan in the US.
The U.S. Food and Drug Administration on Friday approved the Siemens Biograph mMR system for use in the United States. It’s the first device approved to simultaneously perform a positron emission tomography (PET) and magnetic resonance imaging (MRI) scan in the US.
PET/computer tomography (CT) scanners are well known. But the new machine has several advantages over PET/CT, the FDA says, including “simultaneous imaging, reduced radiation dose, and increased soft tissue contrast.
Image courtesy of Siemens
"The Siemens PET/MRI system allows two tests to run simultaneously without having to move the patient to a different scanning system," Alberto Gutierrez, Ph.D., director of the Office of In Vitro Diagnostic Device Evaluation and Safety in the FDA's Center for Devices and Radiological Health. "Minimizing changes in a patient's position between tests allows physicians to compare images more easily and helps them get the most accurate information possible."
The new machine was approved last week for sale in Europe.
As with PET/CT machines, the Biograph mMR uses PET to observe organ and tissue function, but the new machine boasts the superior resolution of MRI, which could provide physicians with more information about a patient’s condition, the FDA said. The agency added that the MRI’s lack of ionizing radiation means the Biograph system exposes patients to a “significantly lower radiation dose” than a PET/CT system. The decreased radiation dose is especially significant for sensitive populations such as children or patients receiving multiple scans, the agency said.
The FDA cleared the Siemens system based on bench tests comparing the device with a PET/CT machine. The Biograph mMR system is indicated for anyone who needs diagnostic PET or MRI imaging, though patients with pacemakers, defibrillators or other implanted electronic devices should avoid the Biograph mMR unless those devices are specifically indicated for use in the highly magnetic environment.
The Biograph mMR is made by Siemens Medical Solutions of Malvern, Pa.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
